These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14632866)

  • 21. Immune normalization strategy against suboptimal health status: safe and efficacious therapy using mixed-natural killer cells.
    Li Y; Harunori O; Fu S; Xing F; Wu H; Wang J; Chen A; Ren X; Peng D; Ling X; Shi M; Wu H
    Aging (Albany NY); 2021 Aug; 13(16):20131-20148. PubMed ID: 34461606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells.
    Deng X; Terunuma H; Terunuma A; Takane T; Nieda M
    Int Immunopharmacol; 2014 Oct; 22(2):486-91. PubMed ID: 25131561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers.
    Kim EK; Ahn YO; Kim S; Kim TM; Keam B; Heo DS
    Cytotherapy; 2013 Feb; 15(2):231-241.e1. PubMed ID: 23321334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
    Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W
    Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment.
    Oyer JL; Pandey V; Igarashi RY; Somanchi SS; Zakari A; Solh M; Lee DA; Altomare DA; Copik AJ
    Cytotherapy; 2016 May; 18(5):653-63. PubMed ID: 27059202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmenting the expression of NKp44 molecule and the natural killer activity in peripheral blood mononuclear cells from patients with malignant colorectal carcinoma.
    Sheikhi A; Saadati K; Jafarzadeh A; Karimi H; Mousavinasab N
    Drug Res (Stuttg); 2014 Jun; 64(6):281-6. PubMed ID: 24154937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded CD56
    Poznanski SM; Nham T; Chew MV; Lee AJ; Hammill JA; Fan IY; Butcher M; Bramson JL; Lee DA; Hirte HW; Ashkar AA
    Cancer Immunol Res; 2018 Oct; 6(10):1174-1185. PubMed ID: 30018043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity.
    Doskali M; Tanaka Y; Ohira M; Ishiyama K; Tashiro H; Chayama K; Ohdan H
    J Immunother; 2011 Mar; 34(2):129-38. PubMed ID: 21304407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells.
    Pandey V; Oyer JL; Igarashi RY; Gitto SB; Copik AJ; Altomare DA
    Oncotarget; 2016 Feb; 7(6):7318-28. PubMed ID: 26802025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
    Platsoucas CD; Oleszak EL; Good RA
    Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
    Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
    J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immunity protein Tag7 (PGRP-S) activates lymphocytes capable of Fasl-Fas-dependent contact killing of virus-infected cells.
    Sharapova TN; Ivanova OK; Prasolov VS; Romanova EA; Sashchenko LP; Yashin DV
    IUBMB Life; 2017 Dec; 69(12):971-977. PubMed ID: 29083508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The interrelation of the expression of HLA class I and II proteins and of the costimulatory proteins CD11a/CD18 and CD16 with the lytic activity of resting and activated natural killer lymphocytes].
    Musatov MI; Petrova ED; Konenkov VI
    Tsitologiia; 1997; 39(7):617-28. PubMed ID: 9490502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.